Validation of a screening protocol for identifying low-risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantation

Clinical Transplantation

Volumn 20, Issue 2, 2006, Pages 139-146

  Ma, Irene Wai Yan ^a,b   Valantine, Hannah A ^c   Shibata, Atsuko ^a   Waskerwitz, Jane ^a   Dafoe, Donald C ^d   Alfrey, Edward J ^e   Tan, Jane C ^a   Millan, Maria ^a   Busque, Stephan ^a   Scandling, John D ^a  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Clinical transplantation; Coronary disease; Diabetes mellitus; Kidney; Risk factors

Indexed keywords

ADULT; AGE DISTRIBUTION; ANGIOCARDIOGRAPHY; CARDIOVASCULAR SYSTEM EXAMINATION; CAUSE OF DEATH; CLINICAL PROTOCOL; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; DIABETIC NEPHROPATHY; DISEASE DURATION; ECG ABNORMALITY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SMOKING; ST SEGMENT; SURGICAL MORTALITY; VALIDATION PROCESS;

AGE OF ONSET; ANALYSIS OF VARIANCE; C-PEPTIDE; CORONARY ARTERY BYPASS; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SMOKING;

EID: 33646074773     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2005.00461.x     Document Type: Review

References (30)

1. Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996: 7: 158.
2. Lindholm A, Albrechtsen D, Frodin L, Tufveson G, Persson NH, Lundgren G. Ischemic heart disease - major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation 1995: 60: 451.
3. Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000: 57: 307.
4. US Renal Data System, USRDS 2004 Annual Data Report. Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003.
5. Lufft V, Dannenberg B, Schlitt HJ, Pichlmayr R, Brunkhorst R. Cardiovascular morbidity and mortality in patients with diabetes mellitus type I after kidney transplantation: A case-control study. Clin Nephrol 2004: 61: 238.
6. Weinrauch LA, D'Elia JA, Healy RW et al. Asymptomatic coronary artery disease: Angiography in diabetic patients before renal transplantation. Relation of findings to postoperative survival. Ann Intern Med 1978: 88: 346.
7. Bennett WM, Kloster F, Rosch J, Barry J, Porter GA. Natural history of asymptomatic coronary arteriographic lesions in diabetic patients with end-stage renal disease. Am J Med 1978: 65: 779.
8. Braun WE, Phillips D, Vidt D et al. The course of coronary artery disease in diabetics with and without renal allografts. Transplant Proc 1983: 15: 1114.
9. Manske CL, Wilson RF, Wang Y, Thomas W. Atherosclerotic vascular complications in diabetic transplant candidates. Am J Kidney Dis 1997: 29: 601.
10. Braun WE, Phillips DF, Vidt DG et al. Coronary artery disease in 100 diabetics with end-stage renal failure. Transplant Proc 1984: 16: 603.
11. Koch M, Gradaus F, Schoebel FC, Leschke M, Grabensee B. Relevance of conventional cardiovascular risk factors for the prediction of coronary artery disease in diabetic patients on renal replacement therapy. Nephrol Dial Transplant 1997: 12: 1187.
12. Manske CL, Thomas W, Wang Y, Wilson RF. Screening diabetic transplant candidates for coronary artery disease: Identification of a low risk subgroup. Kidney Int 1993: 44: 617.
13. Kasiske BL, Cangro CB, Hariharan S et al. The evaluation of renal transplantation candidates: Clinical practice guidelines. Am J Transplant 2002: 1 (Suppl. 2): 1.
14. Murphy SW, Parfrey PS. Screening for cardiovascular disease in dialysis patients. Curr Opin Nephrol Hypertens 1996: 5: 532.
15. Gaston RS, Basadonna G, Cosio FG et al. Transplantation in the diabetic patient with advanced chronic kidney disease: A task force report. Am J Kidney Dis 2004: 44: 529. 529.
16. Danovitch GM, Hariharan S, Pirsch JD et al. Management of the waiting list for cadaveric kidney transplants: Report of a survey and recommendations by the Clinical Practice Guidelines Committee of the American Society of Transplantation. J Am Soc Nephrol 2002: 13: 528.
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999: 130: 461.
18. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine (abstr). J Am Soc Nephrol 2000: 11: 155A.
19. Mistry BM, Bastani B, Solomon H et al. Prognostic value of dipyridamole thallium-201 screening to minimize perioperative cardiac complications in diabetics undergoing kidney or kidney-pancreas transplantation. Clin Transplant 1998: 12: 130.
20. Morrow CE, Schwartz JS, Sutherland DE et al. Predictive value of thallium stress testing for coronary and cardiovascular events in uremic diabetic patients before renal transplantation. Am J Surg 1983: 146: 331.
21. Brown KA, Rimmer J, Haisch C. Noninvasive cardiac risk stratification of diabetic and nondiabetic uremic renal allograft candidates using dipyridamole-thallium-201 imaging and radionuclide ventriculography. Am J Cardiol 1989: 64: 1017.
22. Herzog CA, Marwick TH, Pheley AM, White CW, Rao VK, Dick CD. Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis 1999: 33: 1080.
23. Organ Procurement and Transplantation Network (OPTN). Available at: http://www.OPTN.org. Accessed October 26, 2004.
24. Lewis MS, Wilson RA, Walker KW et al. Validation of an algorithm for predicting cardiac events in renal transplant candidates. Am J Cardiol 2002: 89: 847.
25. Manske CL, Wang Y, Rector T, Wilson RF, White CW. Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 1992: 340: 998.
26. Lorber MI, Van Buren CT, Flechner SM et al. Pretransplant coronary arteriography for diabetic renal transplant recipients. Transplant Proc 1987: 19 (Part 2): 1539.
27. Rostand SG, Kirk KA, Rutsky EA. Dialysis-associated ischemic heart disease: Insights from coronary angiography. Kidney Int 1984: 25: 653.
28. Manske CL, Wilson RF, Wang Y, Thomas W. Prevalence of, and risk factors for, angiographically determined coronary artery disease in type I-diabetic patients with nephropathy. Arch Intern Med 1992: 152: 2450.
29. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998: 32 (Suppl. 3): S112.
30. de Lemos JA, Hillis LD. Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysis. J Am Soc Nephrol 1996: 7: 2044.